Selected data models

You must log in to select data models for download or further analysis.

51 Search results.
Relevance Rating New first Old first

Dose strength equivalence of ropinirole CR in healthy adults Treatment Period 4 101468/219 - Treatment Period 4 Dose strength equivalence of ropinirole CR in healthy adults 101468/219

- 8/17/17 - 1 form, 10 itemgroups, 58 items, 1 language
Itemgroups: Predose Checklist, Pregnancy Test, Drug Screening, Alcohol Breath Test, Vitals Signs, Dosing Details, Vital Signs, Domperidone Dosing Details, Blood Sampling, Adverse Event
Study ID: 101468/219 Clinical Study ID: 101468/219 Study Title:An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Parkinson Disease Documentation part: Treatment Period 4

Dose strength equivalence of ropinirole CR in healthy adults Treatment Period 5 101468/219 - Treatment Period 5 Dose strength equivalence of ropinirole CR in healthy adults 101468/219

- 8/17/17 - 1 form, 10 itemgroups, 58 items, 1 language
Itemgroups: Predose Checklist, Pregnancy Test, Drug Screening, Alcohol Breath Test, Vitals Signs, Dosing Details, Vital Signs, Domperidone Dosing Details, Blood Sampling, Adverse Event
Study ID: 101468/219 Clinical Study ID: 101468/219 Study Title:An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Parkinson Disease Documentation part: Treatment Period 5

Dose strength equivalence of ropinirole CR in healthy adults Treatment Period 1 101468/219 - Treatment Period 1 Dose strength equivalence of ropinirole CR in healthy adults 101468/219

- 8/16/17 - 1 form, 11 itemgroups, 74 items, 1 language
Itemgroups: Predose Checklist, Pregnancy Test, Drug Screening, Alcohol Breath Test, baseline signs and symptoms, Vitals Signs, Dosing Details, Vital Signs, Domperidone Dosing Details, Blood Sampling, Adverse Event
Study ID: 101468/219 Clinical Study ID: 101468/219 Study Title:An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Parkinson Disease Documentation part: Treatment Period 1, Day 1/1-2

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial